Metamotivation Therapy: Is it time to Focus on Metamotivation in Severe Mental Illness?
Metamotivation Therapy: Is it time to Focus on Metamotivation in Severe Mental Illness?
复制标题
DOI：
10.1007/s10879-021-09502-x
复制
发表时间：
2021-04-15
影响因子：
2
通讯作者：
Medalia, Alice
中科院分区：
文献类型：
--
作者：
Hansen, Marie C.;Gertmenian, Enid;Medalia, Alice
元动机疗法通过使用增强元动机和执行功能技能的新方法，针对严重精神疾病(SMI)的动机缺陷。目前的自然主义、非对照队列研究为元动机疗法的方法提供了合理性，并提供了关于试点可行性和有效性的计划评估数据。通过使用率数据和客户满意度调查(CSS-8)评估了试点的可行性。使用成人执行功能巴克利缺陷和生活质量、享受和满意度问卷对试点效果进行评估。平均而言，参与者完成了15/20个疗程；9名参与者(9.4%)在4个疗程之前退出。在提供满意度评分的28人中，90.5%的人表示有一定程度的满意度。元动机疗法的参与者同时完成了基线和随访测量(n=38)，他们在总体执行功能、自我激励和生活质量方面显示出从基线到随访的改善。考虑到这些结果，有必要进行随机对照试验，以优化剂量和评估疗效。
Metamotivation Therapy targets motivational deficits in severe mental illness (SMI) by using the novel approach of enhancing meta-motivation and executive functioning skills. The current naturalistic, uncontrolled cohort study provides the rational for the Metamotivation Therapy approach and program evaluation data on pilot feasibility and efficacy. Pilot feasibility was assessed through utilization data and Client Satisfaction Survey (CSS-8). Pilot effectiveness was assessed using the Barkley Deficits in Executive Functioning for Adults and Quality of Life Enjoyment and Satisfaction Questionnaire. On average, participants completed 15/20 sessions; nine participants (9.4%) dropped out before four sessions. 90.5% of the 28 people providing satisfaction ratings expressed some level of satisfaction. Metamotivation Therapy participants who completed both baseline and follow up measures (n = 38) showed an improvement from baseline to follow-up on overall executive functioning, self-motivation, and quality of life. Given the results, a randomized controlled trial is warranted to optimize dosage and assess efficacy.